Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

NCT06028074 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Malignancies

Interventions

DRUG: GIM122

Sponsor

Georgiamune Inc